主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VTYX
#2090
Ventyx Biosciences, Inc. Common Stock
13.9
7
-0.07%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.07%
每月变动
-0.07%
6个月变化
+454.37%
年变化
+837.58%
前一天收盘价
13.9
8
Open
13.9
7
Bid
Ask
Low
13.9
7
High
13.9
7
交易量
75
市场
股票
医疗保健
VTYX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
70.71 M
71.13 M
71.16 M
71.31 M
71.36 M
—
Valuation ratios
Enterprise value
92.38 M
128.51 M
53.76 M
120.3 M
189.96 M
492.53 M
Price to earnings ratio
-0.92
-1.11
-0.68
-1.32
-2.16
-5.27
Price to sales ratio
—
1 102.7
—
—
—
—
Price to cash flow ratio
-0.86
-1.15
-0.72
-1.4
-2.5
-5.77
Price to book ratio
0.12
0.59
0.08
0.15
0.25
1.06
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.12
0.11
0.11
0.12
0.11
0.44
Return on equity %
0.13
0.12
0.12
0.13
0.12
0.48
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
—
—
—
—
Operating margin %
—
90.05 K
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
81.53 K
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
23.52
17.97
19.57
19.12
17.86
74.53
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.5
0.34
0.36
0.3
0.25
1.25
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.89
3.69
3.22
2.93
2.7
12.55
Net current asset value per share
4.1
3.35
3.41
3.08
2.82
12.66
Tangible book value per share
3.94
3.71
3.26
2.94
2.68
12.59
Working capital per share
3.92
3.17
3.24
2.92
2.66
11.98
Book value per share
3.94
3.71
3.26
2.94
2.68
12.59
新闻
美CPI数据即将公布 美股期指盘前集体走低 | 今夜看点
Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance
Ventyx Biosciences在计划合并前批准高管现金奖励
Ventyx Biosciences approves cash bonus awards for executives ahead of planned merger
Why Eli Lilly Is The IBD Stock Of The Day — Again — As Its Novo Nordisk Rivalry Deepens
Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point
BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio
Eli Lilly Stock Broke Out Following Plan To Acquire Ventyx Biosciences
Stock Market Rallies Broadly To Highs; Nvidia, AMD, Bloom Energy In Focus: Weekly Review
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
礼来(LLY.US)“减肥神药”联合疗法显奇效,免疫疾病治疗版图加速扩张
Biotech Stocks' Dark Winter Is Over. What That Means For Investors.